Best Glutathione Providers in 2026 — Ranked & Reviewed
Glutathione is an antioxidant compounded for skin brightening, detoxification support, and recovery, most often as an injection and sometimes as part of an IV or NAD+ stack. It is prescription-only through a licensed clinician in the US. The providers below all prescribe it as part of a telehealth practice we independently score, rather than selling it as an unregulated supplement.
Lowest verified price: $89/mo75 providers compared
New to Glutathione? Read our full Glutathione guide — evidence, dosing, safety and side effects.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
75 glutathione providers compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.
- ★ Editor's Pick
mainstream telehealth GLP-1 access
From /moCheck pricingCoverage50 statesMedicationsGlutathioneNAD+Sermorelin - Nationwide Coverage
Low-cost compounded GLP-1 nationwide, no membership required
From /moCheck pricingCoverage50 statesMedicationsGlutathioneNAD+Sermorelin bilingual, LegitScript-certified compounded GLP-1
From /moCheck pricingCoverage50 statesMedicationsGlutathioneNAD+Sermorelin- Transparent Pricing
physician-led, pharmacy-transparent compounded GLP-1 with brand-name options
From /moCheck pricingCoverage50 statesMedicationsGlutathioneNAD+Sermorelin compounded semaglutide and tirzepatide at a flat monthly price
From /moCheck pricingCoverageCheck intakeMedicationsGlutathioneNAD+Sermorelinmainstream telehealth GLP-1 access
From /moCheck pricingCoverageCheck intakeMedicationsGHK-CuGlutathioneNAD+Sermorelinthe lowest all-in monthly price we have verified on compounded semaglutide, labs included
From /moCheck pricingCoverage36 statesMedicationsBPC-157GHK-CuGlutathioneGonadorelinkpvMOTS-cnad-plusPT-141retatrutideSermorelinTB-500TesamorelinScience-forward GLP-1 and peptide care, flat-rate dosing, built-in follow-up
From /moCheck pricingCoverage50 statesMedicationsGHK-CuGlutathioneNAD+PT-141Sermorelin
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick mainstream telehealth GLP-1 access | Check pricing | GlutathioneNAD+Sermorelin | 50 states | Visit → | |
Nationwide Coverage Low-cost compounded GLP-1 nationwide, no membership required | Check pricing | GlutathioneNAD+Sermorelin | 50 states | Visit → | |
 bilingual, LegitScript-certified compounded GLP-1 | Check pricing | GlutathioneNAD+Sermorelin | 50 states | Visit → | |
Transparent Pricing physician-led, pharmacy-transparent compounded GLP-1 with brand-name options | Check pricing | GlutathioneNAD+Sermorelin | 50 states | Visit → | |
 compounded semaglutide and tirzepatide at a flat monthly price | Check pricing | GlutathioneNAD+Sermorelin | Check intake | Visit → | |
 mainstream telehealth GLP-1 access | Check pricing | GHK-CuGlutathioneNAD+Sermorelin | Check intake | Visit → | |
 the lowest all-in monthly price we have verified on compounded semaglutide, labs included | Check pricing | BPC-157GHK-CuGlutathioneGonadorelinkpvMOTS-cnad-plusPT-141retatrutideSermorelinTB-500Tesamorelin | 36 states | Visit → | |
 Science-forward GLP-1 and peptide care, flat-rate dosing, built-in follow-up | Check pricing | GHK-CuGlutathioneNAD+PT-141Sermorelin | 50 states | Visit → |
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
Detailed Reviews
A note on prices below: any dollar figure in these provider summaries refers to that clinic’s GLP‑1 weight-loss program, not to Glutathione. The Glutathione price is the one beside each clinic in the comparison table above, read from that clinic’s own product page. Where it reads “Check pricing”, the clinic prescribes Glutathione but publishes no price for it — you are quoted after the consultation.
bmiMD
Verified partnerBest for: mainstream telehealth GLP-1 access
Medical weight loss clinic offering GLP-1 prescriptions through telehealth.
Score Breakdown
Pros
- ✓Both semaglutide and tirzepatide available
Cons
- ✗Cheapest advertised rates require a 12-month prepaid plan — month-to-month is $129 for semaglutide and $139 for sermorelin injection
Kongo
Best for: Low-cost compounded GLP-1 nationwide, no membership required
Kongo (Kongo Health Inc.) is a transparent, no-membership telehealth platform offering compounded GLP-1 weight-loss medication in all 50 states: compounded semaglutide at $119/month and tirzepatide at $229/month, with the provider visit, supplies, and free shipping always included. A 4-minute intake (no video call) gets a licensed-provider decision within 24 hours; prescriptions are compounded by a licensed US pharmacy. Kongo also offers longevity treatments (NAD+, sermorelin). It carries verifiable LegitScript certification; compounded meds are not FDA-approved.
Score Breakdown
Pros
- ✓Among the lowest compounded GLP-1 prices: semaglutide $119/month and tirzepatide $229/month
- ✓Available in all 50 states with no membership fee, and provider, supplies, and free shipping always included
- ✓Verifiable LegitScript certification (seal ID 45229340)
- ✓Fast and simple: 4-minute intake with no video call and provider approval within 24 hours
- ✓Also offers longevity treatments (NAD+, sermorelin, glutathione) if you want more than GLP-1
Cons
- ✗Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- ✗The compounding pharmacy is described only as a 'licensed US pharmacy' and not named
- ✗Newer brand; member testimonials are the main social proof
- ✗Some verticals (Longevity, Intimacy) are still listed as 'coming soon'
REMEVi
Best for: bilingual, LegitScript-certified compounded GLP-1
REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated. It offers compounded semaglutide (from $199/mo on the 52-week plan) and tirzepatide (from $269/mo), provider-managed with weekly titration and overnight shipping from an NPI-verified pharmacy, at the same price every month with no hidden fees and cancel-anytime. REMEVi is LegitScript-certified and licensed in all 50 states plus DC. Compounded meds are not FDA-approved (disclosed); the pharmacy is NPI-verified but not named.
Score Breakdown
Pros
- ✓The first bilingual GLP-1 clinic — care delivered in English and Spanish by clinicians trained in both, not auto-translated
- ✓Compounded semaglutide from $199/mo and tirzepatide from $269/mo on the 52-week plan, with the same price every month (no titration price hikes)
- ✓LegitScript-certified and licensed in all 50 states + DC, with an NPI-verified pharmacy and overnight shipping
- ✓Transparent all-inclusive pricing with no hidden fees and cancel anytime; full legal suite (Privacy, Terms, HIPAA, Refund)
Cons
- ✗Lowest pricing requires a 52-week commitment — month-to-month is higher ($279 semaglutide / $339 tirzepatide)
- ✗Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy or Zepbound
- ✗The specific compounding pharmacy is not named (described as 'NPI-verified')
- ✗A newer, patient-founded clinic; press mentions (Fortune, AP, Reuters) are syndicated PR, not editorial endorsements
RxSpan MD
Verified partnerBest for: physician-led, pharmacy-transparent compounded GLP-1 with brand-name options
RxSpan MD is a physician-led telehealth practice founded by Dr. John Diaz, a board-certified plastic surgeon, offering compounded GLP-1 weight loss — semaglutide and tirzepatide from $249/mo, as injections or oral capsules — plus brand-name Wegovy, Zepbound and Ozempic. It's unusually transparent: it names its 503A pharmacy partners (Belmar, Strive, Epiq Scripts, Casa Pharma) and medical group, ships free, and includes unlimited 24/7 support. Available in all 50 states.
Score Breakdown
Pros
- ✓Physician-led — founded by Dr. John Diaz, a board-certified plastic surgeon with 20+ years' experience
- ✓Compounded semaglutide and tirzepatide from $249/mo (injection or oral capsules), plus brand-name Wegovy, Zepbound and Ozempic
- ✓Names its 503A pharmacy partners (Belmar, Strive, Epiq Scripts, Casa Pharma) and medical group
- ✓LegitScript-certified (#50405601); free expedited shipping and unlimited 24/7 support included
- ✓Available in all 50 states via a 2-minute assessment
Cons
- ✗Compounded pricing ($249 semaglutide / $329 tirzepatide) sits mid-to-high versus the cheapest telehealth options
- ✗Brand-name GLP-1 is priced steeply (Wegovy $1,349, Ozempic $1,299, Zepbound $1,069)
- ✗Multi-vertical practice (also hair, sexual health, longevity), not weight-loss-only
- ✗Legal entity name isn't published on the site
Oak
Verified partnerBest for: compounded semaglutide and tirzepatide at a flat monthly price
Telehealth provider offering compounded GLP-1 medications (semaglutide and tirzepatide) operated by Oak Longevity Holdings Corp. with prescriptions issued through NVP Medical Group, P.A.
Score Breakdown
Pros
- ✓Both compounded semaglutide ($119/mo) and tirzepatide ($185/mo) on a single platform
- ✓$200-off new-patient offer advertised — final discounted price is shown after the intake quiz
- ✓LegitScript-certified pharmacy network
- ✓No video call required for initial approval; flat per-month pricing across all dose strengths
Cons
- ✗Pharmacy partners are not publicly named on the marketing site (material gap for YMYL disclosure)
- ✗Operates in 45 states per Terms of Use, but the public state list is gated behind the signup intake
- ✗No brand-name Wegovy / Zepbound / Mounjaro / Ozempic available — compounded only
- ✗Fees are non-refundable per Terms of Use; binding arbitration under Delaware law
How to choose a glutathione provider
Glutathione is an antioxidant given by injection or IV and sold widely as a supplement. It is not FDA-approved for skin lightening or anti-aging, and the FDA has specifically warned about injectable skin-lightening products — so how a clinic frames it tells you a lot.
What to look for
- Framing you can check. A clinic marketing glutathione primarily for skin lightening is selling an indication regulators have warned about. Oxidative-stress and general-wellness framing, with the limits stated, is the more defensible posture.
- IV versus intramuscular versus oral. IV is clinic-administered and priciest; IM injection is the common at-home form; oral glutathione is poorly absorbed and is a different product entirely. Confirm which one the quoted price covers.
- Sterile compounding you can verify. Any injectable comes from a compounding pharmacy. Ask which one, and whether it is 503A or 503B — sterility is the risk that matters for an injected antioxidant.
Red flags to avoid
- “Research peptides” sold without a prescriber. Vials labelled “for research use only — not for human consumption” are sold outside the drug-approval system entirely, with no verified identity, purity, or sterility. Every peptide in this category is prescription-only in the US; if no licensed clinician is writing a prescription, you are not buying the same product.
- No named 503A or 503B compounding pharmacy. There is no FDA-approved finished product for these peptides, so every legitimate dose comes from a compounding pharmacy. A clinic that will not name the pharmacy it dispenses through is asking you to trust an unverifiable supply chain.
- “FDA-approved” claimed for a compounded peptide. Compounded drugs are not FDA-approved, and saying otherwise is a marketing violation, not a technicality. Some peptides once held an approval for a different indication in a discontinued brand — that is not the same as the compounded product being approved.
- Outcome claims with no trial behind them. Most peptides in this category have mechanistic or early-phase evidence, not randomized outcome trials. A clinic promising a specific fat-loss, muscle, or anti-aging result is selling ahead of the evidence — check our evidence review for the molecule before you commit.
- No baseline labs or follow-up for hormone-axis peptides. Growth-hormone secretagogues raise IGF-1, which is the point and also the thing to monitor. A clinic that never measures it cannot tell whether you are responding or over-dosed.
Every provider ranked above is scored against these criteria across our six-dimension methodology, and prices are re-verified against each provider’s live site.
How we rank & what counts as “legit”
Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.
Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].
Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- 503A pharmacy · Pharmacy and drug forms
- 503A vs 503B (pharmacy compounding) · Pharmacy and drug forms
- 503B outsourcing facility · Pharmacy and drug forms
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.